Related Experiment Video

Updated: Aug 17, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Respiratory syncytial virus infection in infants and young children

B T Levy1, M A Graber

  • 1Department of Family Medicine, University of Iowa, Iowa City 52242, USA. barcey-levy@uiowa.edu

The Journal of Family Practice
|January 8, 1998
PubMed

Insights

Respiratory syncytial virus (RSV) causes frequent infant infections, leading to hospitalizations and significant costs. Supportive care is primary, with bronchodilators showing benefit for acute bronchiolitis.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children.
  • RSV epidemics occur annually, resulting in substantial healthcare utilization and costs in the United States.
  • Clinical manifestations include respiratory distress, wheezing, and dehydration, with potential complications like apnea and significant mortality in hospitalized infants.

Purpose of the Study:

  • To summarize the epidemiology, clinical presentation, diagnosis, and management of Respiratory Syncytial Virus (RSV) infections.
  • To evaluate the efficacy of various therapeutic interventions for RSV-induced acute bronchiolitis.

Main Methods:

  • Review of clinical findings and diagnostic approaches for RSV.
  • Analysis of evidence regarding therapeutic options, including bronchodilators, steroids, ribavirin, and prophylaxis.

Main Results:

  • Diagnosis relies on clinical presentation, seasonal patterns, and microbiologic testing.
  • Supportive care is the mainstay of therapy; bronchodilators (epinephrine, albuterol) appear beneficial for acute bronchiolitis.
  • Steroids show no advantage, and ribavirin is reserved for high-risk infants. Prophylaxis with RSV immune globulin may benefit specific infant populations.

Conclusions:

  • RSV infection management requires a comprehensive approach, balancing supportive care with targeted interventions.
  • Bronchodilators are recommended for acute bronchiolitis, while other therapies have specific indications or limited efficacy.
  • Risk stratification and targeted prophylaxis are crucial for managing severe RSV disease in vulnerable infants.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...